Avidity Biosciences, Inc.RNANASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-10.32%
↑ 47% above average
Average (26q)
-19.62%
Historical baseline
Range
High:10.60%
Low:-79.62%
Volatility
-459.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -10.32% |
| Q2 2025 | -30.13% |
| Q1 2025 | -8.70% |
| Q4 2024 | -23.29% |
| Q3 2024 | -18.77% |
| Q2 2024 | -7.05% |
| Q1 2024 | -15.65% |
| Q4 2023 | -13.85% |
| Q3 2023 | -11.38% |
| Q2 2023 | 8.62% |
| Q1 2023 | -8.21% |
| Q4 2022 | -18.46% |
| Q3 2022 | 2.96% |
| Q2 2022 | -34.36% |
| Q1 2022 | 10.60% |
| Q4 2021 | -31.65% |
| Q3 2021 | -11.05% |
| Q2 2021 | -10.52% |
| Q1 2021 | -46.42% |
| Q4 2020 | -42.10% |
| Q3 2020 | -10.59% |
| Q2 2020 | -68.59% |
| Q1 2020 | -1.70% |
| Q4 2019 | -16.15% |
| Q3 2019 | -33.32% |
| Q2 2019 | -79.62% |
| Q1 2019 | 0.00% |